# Study of MOC31-PE in Antigen Positive Carcinomas

> **NCT01061645** · PHASE1 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 20 (actual)

## Conditions studied

- Carcinoma

## Interventions

- **DRUG:** MOC31-PE

## Key facts

- **NCT ID:** NCT01061645
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01061645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01061645, "Study of MOC31-PE in Antigen Positive Carcinomas". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01061645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*